In our previous work, we measured the levels of serum IP-10, SAA, and sialic acid and circulating plasma has-mir-155-5p in positive COVID-19 patients to explore their clinical values and significance in discrimination between moderate and severe COVID-19 infection and predicting the severity and prognosis of COVID-19 disease [18–21]. This evidence concerns the gene CXCL10 and COVID-19.